All News #Library
Biotech
GSK Props Up Its Cabenuva In Adolescents With Long-Term Data
26 Feb 2026 //
FIERCE PHARMA
Viiv Pharma Unveils Long-Acting HIV Breakthroughs At CROI 2026
17 Feb 2026 //
BUSINESSWIRE
Shionogi boosts ViiV stake in $2.13 billion deal as Pfizer exits
19 Jan 2026 //
REUTERS
GSK Tout Study Showing Tolerability Edge for Its Long-Acting PrEP
15 Oct 2025 //
FIERCE PHARMA
GSK posts data on HIV assets vying for roles in 6-month combo
13 Mar 2025 //
PRESS RELEASE
ViiV Healthcare: Zero HIV cases with Apretude in new study
12 Mar 2025 //
BUSINESSWIRE
GSK`s injectable HIV drug shows promise over daily pills
22 Feb 2024 //
PRESS RELEASE
ViiV brings together sons and mothers in new initiative for HIV
30 May 2023 //
FIERCE PHARMA

Market Place
Sourcing Support